Questions to Ask Before Hiring an AI Healthcare Dev Partner

For: COO or product lead at a mid-sized healthcare or health-adjacent business — a diagnostic chain, a hospital group, a health insurance TPA, or a wellness platform — who has budget approved for an AI feature or digitization project and is now sitting across the table from dev shop proposals they cannot meaningfully distinguish from each other

If you can only ask one question, ask this: Describe a moment when a clinician, a regulator, or a real patient dataset forced you to redesign your model's output layer or rework your data pipeline. Vendors who have only built healthcare demos cannot answer it. The rest of this post is fifteen more questions in the same spirit — sharp enough to separate an AI healthcare development partner who has shipped inside HIPAA, ABDM, and HL7/FHIR reality from one who assembled a portfolio from generic ML work.

Use these in your next vendor call. Score answers on specificity, not polish.

Clinical and regulatory grounding

1. Walk me through your last HIPAA (or ABDM, or GDPR-health) audit. Who ran it and what did you fix?

Why it matters: Compliance is a verb. Anyone can claim "HIPAA-aware." Few have sat through a real Business Associate Agreement review or an ABDM sandbox certification cycle.

Good answer: They name the auditor or the certification body, describe two or three specific findings (audit log retention, encryption key rotation, an over-permissive IAM role), and explain what they changed in their SDLC afterward.

Red flag: "We follow HIPAA best practices" with no specifics. Or worse, they conflate HIPAA with SOC 2 and assume one implies the other.

2. Have you integrated with HL7 v2, FHIR, or a hospital HIS/LIS in production? Which one, which version, and what broke?

Why it matters: FHIR slides nicely in a demo. Real hospital integrations involve quirky ADT feeds, legacy MLLP over VPN, custom Z-segments, and an integration engineer at the hospital who answers email twice a week.

Good answer: They name the EMR (Epic, Cerner, eClinicalWorks, Bahmni), the message types they handled (ORU^R01, ADT^A08), and a war story — maybe a timezone bug in observation timestamps that took three weeks to find.

Red flag: "FHIR is straightforward, we use the standard libraries." Nobody who has shipped in this space says that.

3. How do you handle PHI in your training and evaluation pipelines?

Why it matters: A lot of AI vendors quietly pipe production data into a notebook on someone's laptop. That is the kind of mistake that ends with a breach notification letter.

Good answer: De-identification using a documented method (Safe Harbor or Expert Determination), synthetic data for early experimentation, segregated training environments with audit logs, and a clear policy that nothing leaves the controlled environment.

Red flag: They mention sending data to a third-party labeling vendor without explaining the BAA chain.

4. What is your stance on using patient data with foundation model APIs (OpenAI, Anthropic, Gemini)?

Why it matters: This is the live wire in 2025 healthcare AI. The answer reveals how seriously they think about data residency, BAAs with model providers, and the difference between a hosted endpoint and a deployed weight.

Good answer: They distinguish between providers with healthcare-grade BAAs (Azure OpenAI, AWS Bedrock with certain models) and consumer APIs, explain when they recommend self-hosted open-weight models (Llama, Mistral, MedGemma), and have a documented data-flow diagram for any LLM call touching PHI.

Red flag: "We just call GPT-4, it's fine."

The clinical-reality test

5. Tell me about a time clinical feedback forced you to change a model's output.

Why it matters: This is the core diagnostic question. Vendors with real experience have a story. Vendors without one will reach for generic language about "iteration" and "feedback loops."

Good answer: Something like: "Our triage classifier returned probability scores. The ER physicians said the scores were useless to them — they wanted a recommended disposition with a confidence band and the top three contributing factors. We rebuilt the output layer and the UI around that."

Red flag: A polished story about "working closely with stakeholders" with no specific change described.

6. Who on your team has worked alongside clinicians, and in what capacity?

Why it matters: You do not need an MD on staff. You do need at least one person who has spent real hours watching nurses use software at 2 a.m.

Good answer: Named clinical advisors, a product manager with hospital ops background, or developers who have done shadowing sessions in the wards where their software will run.

Red flag: "We have domain experts available on demand." That means nobody full-time.

7. How do you handle model uncertainty and abstention?

Why it matters: In healthcare, a confident wrong answer is worse than no answer. A serious AI partner has thought about when the model should refuse to answer.

Good answer: Calibrated confidence scores, explicit abstention thresholds tied to clinical risk, fallback to human review, and instrumentation that tracks how often the system abstains.

Red flag: Accuracy numbers presented without a confusion matrix or false-negative discussion.

8. Show me a case where your system made a clinically meaningful error in testing. What did you do?

Why it matters: Every real system has these. The question is whether they have a process for catching and learning from them.

Good answer: They describe the error (e.g., the drug interaction checker missed a class effect because the training data was coded at brand level), the root cause, the fix, and the regression test they added.

Red flag: "Our model achieved 97% accuracy in validation" as the entire answer.

Engineering and architecture

9. Walk me through the architecture of a healthcare product you have shipped.

Why it matters: You want to see if they think about audit logging, role-based access at the data level, encryption at rest and in transit with key management, and disaster recovery — not just microservices diagrams.

Good answer: They draw it on the whiteboard. They mention PHI boundaries, BAA-covered services, audit trails, and how they handle backups containing PHI. For India: how they handle ABDM consent artefacts. HealthPotli is one example of an e-pharmacy stack with AI-driven drug interaction checks where these boundaries matter.

Red flag: The architecture diagram looks identical to a generic e-commerce app with "AI service" added in a box.

10. How do you version and govern models in production?

Why it matters: A model that drifts silently is a liability. Healthcare regulators (and your compliance officer) will eventually ask which version of which model produced a given output six months ago.

Good answer: Model registry (MLflow, SageMaker Model Registry, or in-house), immutable inference logs tying request to model version, drift monitoring, and a rollback procedure that has actually been used.

Red flag: "We retrain when accuracy drops." With no monitoring described.

11. How do you approach evaluation beyond accuracy?

Why it matters: A model can be 95% accurate and still useless if the 5% errors cluster in the elderly, or in a specific comorbidity, or one language.

Good answer: Subgroup analysis, fairness metrics across age/sex/site, clinical utility metrics (sensitivity at fixed specificity, net benefit), and prospective silent-mode evaluation before go-live.

Red flag: A single ROC-AUC number.

12. What does your CI/CD pipeline look like for a model update?

Why it matters: Code can ship in hours. Models touching clinical decisions should not.

Good answer: Staged rollout, shadow deployment against historical cases, sign-off by a clinical reviewer, and feature flags so a bad model can be disabled in seconds.

Red flag: Same pipeline as their marketing website.

Commercials, IP, and exit

13. Who owns the model weights, the training data, and the code at the end of the engagement?

Why it matters: Some vendors retain weights as their IP and license them back to you. That is fine if disclosed. It is not fine if you discover it on contract termination.

Good answer: Full IP transfer to you, including weights, training scripts, and documentation. Or a clearly disclosed licensing arrangement with exit terms.

Red flag: Vague language about "shared IP" or a refusal to put ownership in writing. This is one of the reasons buyers vet a healthcare software development company on IP terms before scope.

14. What is your handover and exit plan if we want to bring this in-house in 18 months?

Why it matters: A good partner makes themselves replaceable. A bad one builds in dependencies.

Good answer: Documented runbooks, knowledge-transfer sessions, no proprietary runtime dependencies, infrastructure-as-code in your cloud account, and a named person who will train your team.

Red flag: Code that runs only on their hosted platform.

15. Show me three reference customers in healthcare I can actually call.

Why it matters: Logos on a website are not references. A real reference will tell you what went wrong, not just what went right.

Good answer: Three names, three phone numbers, no hesitation. Ideally one project that was hard.

Red flag: NDAs cited as the reason no reference is available. Common for one client, suspicious for all of them.

16. What kinds of healthcare projects do you turn down?

Why it matters: A serious partner has a no-list. It tells you they understand their limits.

Good answer: "We do not do FDA Class III SaMD. We do not do radiology diagnostic models without a clinical co-development partner. We will not deploy LLMs as the primary decision-maker for medication dosing."

Red flag: "We can do anything in healthcare AI."

How to score the conversation

Tally the questions where you got a specific, story-driven answer versus a generic one. If more than four answers were generic, you are talking to a generalist shop that added healthcare to their service menu. That is not necessarily disqualifying — but you should price the risk accordingly, or bring in a clinical advisor of your own to fill the gap.

The vendors worth hiring will, somewhere in the conversation, push back on something you said. They will tell you your proposed feature is the wrong starting point, or that your data is not ready, or that the regulatory path you assumed does not apply. That pushback is the signal.

Frequently Asked Questions

What is the difference between a healthcare AI vendor and a general AI development company?

A healthcare-specific partner has shipped under HIPAA, ABDM, or equivalent regimes, integrated with at least one EMR or HIS in production, and worked through the clinical-validation and evaluation steps that generic AI shops skip. They will also have opinions about which foundation models are safe to use with PHI and why. A general AI company can sometimes ramp up, but you are paying for their learning curve.

How important is FHIR experience when hiring a healthcare AI developer?

Important if you are integrating with hospital systems, payer systems, or a national health stack like ABDM in India or TEFCA in the US. Less critical if you are building a standalone wellness or consumer health product. Ask the vendor to describe a specific FHIR resource they have worked with (Observation, MedicationRequest, Encounter) and a bug they hit — that surfaces real experience quickly.

Should the AI healthcare development partner host the model, or should we?

Generally, you should — in your own cloud account, under your own BAAs, with your own audit trails. Vendor-hosted models complicate compliance, data residency, and exit. Exceptions exist for early prototypes or when the vendor offers a regulated, audited managed service with clearly disclosed terms.

How do we evaluate proposals when costs and timelines vary widely between vendors?

Normalize on scope, not headline numbers. Ask each vendor to break down the same scope into the same milestones, with the same deliverables, the same compliance artefacts, and the same handover terms. Cost differences then become legible. For a personalized assessment of scope and approach for your specific project, contact CodeNicely.

What is the single biggest mistake buyers make when hiring an AI healthcare development partner?

Hiring based on a polished case-study deck without calling references or asking the vendor to describe a failure. The case study page is marketing. The phone call with a previous client, and the war-story answer to question 5 above, is the actual evidence.